Vitamin B3 pill shows promise in Alzheimer's Dose-Finding study
NCT ID NCT05617508
First seen Dec 11, 2025 · Last updated May 23, 2026 · Updated 23 times
Summary
This study tested different doses of nicotinamide riboside (a form of vitamin B3) in 80 people with early Alzheimer's disease. The goal was to find the dose that best boosts brain energy levels without causing side effects. Participants took pills daily for 12 weeks and had brain scans and spinal fluid tests. The study does not aim to cure Alzheimer's but to see if this supplement can improve brain cell function.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DEMENTIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Haraldsplass Deaconess Hospital
Bergen, Vestland, 5009, Norway
-
Haukeland University Hospital
Bergen, Vestland, 5021, Norway
Conditions
Explore the condition pages connected to this study.